(E1)levating COVID-19 vaccine efficiency with adenoviral E1 proteins.
Where this comes from
- Record sourced from PubMed, PMID 36001673.
- Also identified by DOI 10.1126/sciadv.ade3956 and PMC identifier 11325920.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Improved adenovirus-based COVID-19 vaccines provide an important tool to combat the ever-evolving virus.